| Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) (NCT06057402) | Pfizer | 2023-10-03 |
| Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself. (NCT06086340) | Pfizer | 2023-09-29 |
| A Study to Learn More About the Menopausal Hormone Therapies in Korea (NCT06033521) | Pfizer | 2023-09-12 |
| Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data (NCT06199934) | Pfizer | 2023-09-11 |
| A Study to Evaluate the Study Medication (Etrasimod) When Mixed With Food in Healthy Participants (NCT05956002) | Pfizer | 2023-09-04 |
| A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US (NCT06504524) | Pfizer | 2023-09-01 |
| A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants. (NCT05994963) | Pfizer | 2023-09-01 |
| A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid Cardiomyopathy (Attrwt-CM) And Non-Amyloid Heart Failure Among Patients With Heart Failure (HF). (NCT06029452) | Pfizer | 2023-09-01 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-06954522 Are Tolerated and Act in the Body in Healthy Adults (NCT06003777) | Pfizer | 2023-08-30 |
| A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma. (NCT05896163) | Pfizer | 2023-08-30 |
| A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis (NCT05995964) | Pfizer | 2023-08-22 |
| A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants (NCT06005688) | Pfizer | 2023-08-18 |
| A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India. (NCT05875727) | Pfizer | 2023-08-16 |
| Voxelotor Brain Oxygenation and Neurocognitive Study (NCT05228821) | Pfizer | 2023-08-09 |
| Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer (NCT05909397) | Pfizer | 2023-08-09 |
| A Study to Learn About the Study Medicine (PF-07293893) at Different Dose Levels in Healthy Adults (NCT05907395) | Pfizer | 2023-08-09 |
| Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT05626322) | Pfizer | 2023-08-04 |
| A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants. (NCT06003829) | Pfizer | 2023-07-31 |
| A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring (NCT05721937) | Pfizer | 2023-07-25 |
| A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer (NCT05968599) | Pfizer | 2023-07-24 |
| A Study to Compare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial Settings (NCT05954546) | Pfizer | 2023-07-21 |
| A Study for Multiple Tablet Forms of The Study Medicine (PF-07220060) in Healthy Adults (NCT05923411) | Pfizer | 2023-07-11 |
| A Study to Compare Zavegepant Concentration Using Samples Collected From the Vein Versus Patient-Centric Microsampling (NCT05948085) | Pfizer | 2023-07-10 |
| A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. (NCT05879718) | Pfizer | 2023-07-07 |
| A Study to Learn About the Effects of Medicines That Help in Thinning the Blood in People With Atrial Fibrillation (AF) Between 2016 and 2020 in France (NCT05838664) | Pfizer | 2023-07-07 |
| Study of GBT021601 in Participants With Renal Impairment (NCT05878704) | Pfizer | 2023-06-29 |
| A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China (NCT05896774) | Pfizer | 2023-06-28 |
| A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway. (NCT05834348) | Pfizer | 2023-06-23 |
| A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age (NCT05900154) | Pfizer | 2023-06-22 |
| A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883. (NCT05884554) | Pfizer | 2023-06-15 |
| A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma (NCT05926960) | Pfizer | 2023-06-13 |
| A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy Adults (NCT05930925) | Pfizer | 2023-06-12 |
| A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine Rosuvastatin (NCT05898672) | Pfizer | 2023-06-09 |
| A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants. (NCT05857644) | Pfizer | 2023-06-07 |
| A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV). (NCT05886777) | Pfizer | 2023-06-05 |
| A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults (NCT05890105) | Pfizer | 2023-06-02 |
| A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma (NCT05932290) | Pfizer | 2023-06-01 |
| A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases (NCT05742217) | Pfizer | 2023-05-26 |
| A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized (NCT05799495) | Pfizer | 2023-05-23 |
| A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] (NCT05895786) | Pfizer | 2023-05-20 |
| A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL (NCT05748171) | Pfizer | 2023-05-17 |
| A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects. (NCT05810038) | Pfizer | 2023-05-15 |
| A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants. (NCT05878522) | Pfizer | 2023-05-15 |
| A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants (NCT05852340) | Pfizer | 2023-05-09 |
| This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times. (NCT05858450) | Pfizer | 2023-05-05 |
| A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States. (NCT05873751) | Pfizer | 2023-04-24 |
| A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults (NCT05831124) | Pfizer | 2023-04-19 |
| Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections (NCT05639647) | Pfizer | 2023-04-18 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 Are Tolerated and Act in the Body in Healthy Adults (NCT05807490) | Pfizer | 2023-04-05 |
| A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants (NCT05788328) | Pfizer | 2023-03-27 |
| To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults (NCT05805826) | Pfizer | 2023-03-23 |
| A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV (NCT05794191) | Pfizer | 2023-03-22 |
| A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants. (NCT05767905) | Pfizer | 2023-03-17 |
| A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy. (NCT05689164) | Pfizer | 2023-03-13 |
| Treatment Patterns Among Patients With Venous Thromboembolism in the United States (NCT05795062) | Pfizer | 2023-03-10 |
| A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults (NCT05788237) | Pfizer | 2023-03-09 |
| A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis. (NCT05689151) | Pfizer | 2023-03-09 |
| A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer (NCT05699135) | Pfizer | 2023-03-09 |
| A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment (NCT05597085) | Pfizer | 2023-03-08 |
| A Study to Examine the Clinical Effectiveness of Tafamidis in Patients With Mixed Phenotype Hereditary Transthyretin Amyloidosis (NCT05139680) | Pfizer | 2023-03-08 |
| A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer (NCT05654623) | Pfizer | 2023-03-03 |
| A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age (NCT05650333) | Pfizer | 2023-03-02 |
| TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) (NCT05573555) | Pfizer | 2023-03-01 |
| A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT05687032) | Pfizer | 2023-02-24 |
| A Study to Understand the Effect of Itraconazole on the Levels of a Study Medicine Called ARV-471 in Healthy Adults (NCT05538312) | Pfizer | 2023-02-23 |
| A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine. (NCT05745142) | Pfizer | 2023-02-23 |
| TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A) (NCT05548127) | Pfizer | 2023-02-23 |
| A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults (NCT05745701) | Pfizer | 2023-02-22 |
| A Study to Learn About the Study Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Advanced Breast Cancer in China (NCT05732428) | Pfizer | 2023-02-20 |
| Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland (NCT05701007) | Pfizer | 2023-02-13 |
| A Study to Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult Participants (NCT05712460) | Pfizer | 2023-02-08 |
| Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi (NCT05630976) | Pfizer | 2023-02-07 |
| Ngenla Subcutaneous Injection Special Investigation (NCT05602766) | Pfizer | 2023-02-06 |
| A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy Adults (NCT05673889) | Pfizer | 2023-01-27 |
| A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults (NCT05703607) | Pfizer | 2023-01-25 |
| A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range (NCT05671653) | Pfizer | 2023-01-19 |
| A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer (NCT05568407) | Pfizer | 2023-01-18 |
| A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese (NCT05677867) | Pfizer | 2023-01-18 |
| A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection (NCT05732454) | Pfizer | 2023-01-18 |
| A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis (NCT05391061) | Pfizer | 2023-01-07 |
| Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively (NCT05568719) | Pfizer | 2022-12-28 |
| A GBT021601 ADME Microtracer Study in Healthy Volunteers (NCT05718687) | Pfizer | 2022-12-22 |
| A Study to Understand How the Study Medicine (PF-07081532) is Processed and Eliminated in Healthy Men (NCT05652647) | Pfizer | 2022-12-21 |
| A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis (NCT05287126) | Pfizer | 2022-12-16 |
| A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma (NCT05675449) | Pfizer | 2022-12-14 |
| A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19 (NCT05545319) | Pfizer | 2022-12-13 |
| Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children (NCT05634811) | Pfizer | 2022-12-12 |
| A Study to Learn About the Medicine (PF-07321332 or Nirmatrelvir/Ritonavir) in Healthy Lactating Women (NCT05441215) | Pfizer | 2022-12-12 |
| A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults (NCT05652660) | Pfizer | 2022-12-09 |
| A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B (NCT05611801) | Pfizer | 2022-12-09 |
| A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo (NCT05583526) | Pfizer | 2022-12-01 |
| A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors (NCT05538130) | Pfizer | 2022-11-30 |
| A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old. (NCT05295290) | Pfizer | 2022-11-21 |
| Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 (NCT05546476) | Pfizer | 2022-11-21 |
| A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting (NCT05487703) | Pfizer | 2022-11-14 |
| This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry (NCT05375942) | Pfizer | 2022-11-11 |
| A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant (NCT05623020) | Pfizer | 2022-11-10 |
| Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications (NCT05518123) | Pfizer | 2022-11-07 |
| A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis (NCT05549323) | Pfizer | 2022-11-07 |
| A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies (NCT05567887) | Pfizer | 2022-11-02 |